IL-36 receptor antagonist with special emphasis on IL-38

Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):27-36. doi: 10.1177/039463201302600103.

Abstract

IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFkB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Humans
  • Interleukins / immunology*
  • Receptors, Interleukin / antagonists & inhibitors*
  • Receptors, Interleukin / immunology

Substances

  • Anti-Inflammatory Agents
  • IL-38 protein, human
  • Interleukins
  • Receptors, Interleukin
  • interleukin-36 receptor, human